InspireMD Inc (NSPR) - Product Pipeline Analysis, 2025 Update
Description
Summary
InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, acute myocardial infarction and saphenous vein graft coronary intervention. It utilizes MicroNet stent platform technology to develop its products and offers solutions for various disease conditions such as stenting, embolic showers, restenosis and late stent thrombosis. The company markets its products through a network of distributors in Israel and Germany. InspireMD is headquartered in Tel Aviv, Israel.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, acute myocardial infarction and saphenous vein graft coronary intervention. It utilizes MicroNet stent platform technology to develop its products and offers solutions for various disease conditions such as stenting, embolic showers, restenosis and late stent thrombosis. The company markets its products through a network of distributors in Israel and Germany. InspireMD is headquartered in Tel Aviv, Israel.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InspireMD Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
37 Pages
- InspireMD Inc Company Overview
- InspireMD Inc Company Snapshot
- InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
- InspireMD Inc – Pipeline Analysis Overview
- InspireMD Inc - Key Facts
- InspireMD Inc - Major Products and Services
- InspireMD Inc Pipeline Products by Development Stage
- InspireMD Inc Ongoing Clinical Trials by Trial Status
- InspireMD Inc Pipeline Products Overview
- CGuard Embolic Prevention System
- CGuard Embolic Prevention System Product Overview
- CGuard Embolic Prevention System Clinical Trial
- MGuard Drug Eluting Stent
- MGuard Drug Eluting Stent Product Overview
- Next Gen CGuard - 5F
- Next Gen CGuard - 5F Product Overview
- Next Generation Delivery System
- Next Generation Delivery System Product Overview
- NGuard
- NGuard Product Overview
- PVGuard Peripheral
- PVGuard Peripheral Product Overview
- RGuard Renal
- RGuard Renal Product Overview
- SwitchGuard Neuroprotection System
- SwitchGuard Neuroprotection System Product Overview
- SwitchGuard Neuroprotection System Clinical Trial
- InspireMD Inc - Key Competitors
- InspireMD Inc - Key Employees
- InspireMD Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- InspireMD Inc, Recent Developments
- Jan 12, 2026: InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)
- Dec 19, 2025: InspireMD Announces Board Changes
- Nov 24, 2025: Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
- Nov 04, 2025: InspireMD Reports Third Quarter 2025 Financial Results
- Nov 03, 2025: InspireMD Appoints Peter A. Soukas, M.D., as Chief Medical Officer
- Sep 17, 2025: InspireMD Appoints Dan Dearen to Board of Directors
- Jul 09, 2025: Inspiremd Announces U.S. Commercial Launch of CGuard Prime Carotid Stent System for the Prevention of Stroke
- Jul 09, 2025: InspireMD Obtains PMA Approval for CGuard Prime Carotid Stent System
- Jun 24, 2025: InspireMD Announces FDA Approval for CGuard Prime Carotid Stent System for the Prevention of Stroke
- Jun 16, 2025: InspireMD's embolic prevention system gains CE Mark approval
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview
- InspireMD Inc Pipeline Products by Equipment Type
- InspireMD Inc Pipeline Products by Indication
- InspireMD Inc Ongoing Clinical Trials by Trial Status
- InspireMD Inc, Key Facts
- InspireMD Inc, Major Products and Services
- InspireMD Inc Number of Pipeline Products by Development Stage
- InspireMD Inc Pipeline Products Summary by Development Stage
- InspireMD Inc Ongoing Clinical Trials by Trial Status
- InspireMD Inc Ongoing Clinical Trials Summary
- CGuard Embolic Prevention System - Product Status
- CGuard Embolic Prevention System - Product Description
- CGuard Embolic Prevention System - Acute Stroke of Carotid Artery Bifurcation Origin Treated with Use of the Micronet-covered CGUARD Stent Under Transient Flow Reversal Linked with Thrombus Retrieval: SAFEGUARD-STROKE Study
- CGuard Embolic Prevention System - An Early Feasibility Study (EFS) Assessing the CGuard Embolic Prevention Carotid Stent to Treat Severe Carotid Stenosis or Occlusion
- CGuard Embolic Prevention System - Long-term Outcomes of MicroNet-covered Stent Routine Use for Stroke Prevention in Symptomatic and Increased-risk Asymptomatic Carotid Stenosis Patients Requiring Revascularization by Neurovascular Team Decision: PARADIGM-EXTEND
- CGuard Embolic Prevention System - OPTIMAl Endovascular Exclusion of High-risk Carotid Plaque Using the CGuard Stent in Patients with Symptoms or Signs of Carotid Stenosis-related Brain Injury: IVUS Controlled Investigator Initiated Multcentric Multi-specialty Study
- MGuard Drug Eluting Stent - Product Status
- MGuard Drug Eluting Stent - Product Description
- Next Gen CGuard - 5F - Product Status
- Next Gen CGuard - 5F - Product Description
- Next Generation Delivery System - Product Status
- Next Generation Delivery System - Product Description
- NGuard - Product Status
- NGuard - Product Description
- PVGuard Peripheral - Product Status
- PVGuard Peripheral - Product Description
- RGuard Renal - Product Status
- RGuard Renal - Product Description
- SwitchGuard Neuroprotection System - Product Status
- SwitchGuard Neuroprotection System - Product Description
- SwitchGuard Neuroprotection System - A Multicenter, Single-arm, Pivotal Study to Evaluate the Safety and Efficacy of the SwitchGuard Neuroprotection System (NPS) for Providing Cerebral Embolic Protection During Carotid Artery Stenting Via the Transcarotid Artery Revascularization (TCAR) Approach When Used in Conjunction With the CGuard Prime 80 Carotid Stent System
- SwitchGuard Neuroprotection System - A Study to Evaluate the Efficacy of SwitchGuard Neuroprotection System in Transcarotid Artery Revascularization Procedures
- InspireMD Inc, Key Employees
- InspireMD Inc, Other Locations
- Glossary
- List of Figures
- InspireMD Inc Pipeline Products by Equipment Type
- InspireMD Inc Pipeline Products by Development Stage
- InspireMD Inc Ongoing Clinical Trials by Trial Status
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
